ILF2 Antikörper (AA 1-390)
Kurzübersicht für ILF2 Antikörper (AA 1-390) (ABIN7156716)
Target
Alle ILF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-390
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Interleukin enhancer-binding factor 2 protein (1-390AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Andere Bezeichnung
- ILF2
-
Hintergrund
-
Background: EIF3S2 is the largest of the EIFs. It consists of at least 10 nonidentical subunits in mammals. In S. cerevisiae the p39 subunit contains WD repeats, these are thought to mediate protein-protein interactions. The p39 protein appears to be essential for maintaining the integrity of the yeast EIF3 complex. The mammalian EIF3-p36 subunit is homologous to yeast p39.
Aliases: HGNC:6037 antibody, ILF 2 antibody, ilf2 antibody, ILF2_HUMAN antibody, Interleukin enhancer binding factor 2 antibody, Interleukin enhancer binding factor 2, 45 kDa antibody, Interleukin enhancer-binding factor 2 antibody, MGC8391 antibody, NF 45 antibody, NF45 antibody, Nuclear factor of activated T cells 45 kDa antibody, Nuclear factor of activated T-cells 45 kDa antibody, PRO3063 antibody
-
UniProt
- Q12905
Target
-